Sustainable Sea of Internet of Things: Wind Energy Harvesting System for Unmanned Surface Vehicles by Hao Cao (2248066)

Sustainable Sea of Internet of Things: Wind Energy Harvesting System for Unmanned Surface Vehicles by Hao Cao (2248066)

Sustainable Sea of Internet of Things: Wind Energy Harvesting System for Unmanned Surface Vehicles by Hao Cao (2248066)

Greenhouse Gas and Air Pollutant Emissions from Composting by Sarah L. Nordahl (9148006)

Air/Liquid Interfacial Self-Assembled Intrinsically Stretchable IDT-BT Film Combining a Deliberate Transfer Adherence Strategy for Stretchable Electronics by Jing Sun (141206)

Nano-CT analysis of human brain neurons. by Ryuta Mizutani (4512997)

Primary and Secondary antibodies used. by Vidya G. Bettada (22208808)

Alignment of SNAT6 homologs. by Gaétan Roy (187604)

Bidirectional Optical Control of Proton Motive Force in Escherichia coli Using Microbial Rhodopsins by Kotaro Nakanishi (3389300)

Bidirectional Optical Control of Proton Motive Force in Escherichia coli Using Microbial Rhodopsins by Kotaro Nakanishi (3389300)

Bidirectional Optical Control of Proton Motive Force in Escherichia coli Using Microbial Rhodopsins by Kotaro Nakanishi (3389300)

Bidirectional Optical Control of Proton Motive Force in Escherichia coli Using Microbial Rhodopsins by Kotaro Nakanishi (3389300)

Image_1_The P2X7 Receptor 489C>T Gain of Function Polymorphism Favors HHV-6A Infection and Associates With Female Idiopathic Infertility.tif by Anna Pegoraro (8213589)

“…We show that functional P2X7R increases while its blockade decreases viral load. …”

Image_3_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”

Image_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”

Image_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”

Table_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx by Majd Jawad (12157533)

“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”

Table_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx by Majd Jawad (12157533)

“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”

Table_5_Genome-Wide DNA Methylation and Hydroxymethylation Changes Revealed Epigenetic Regulation of Neuromodulation and Myelination in Yak Hypothalamus.XLSX by Zhixin Chai (6245039)

“…Genome-wide profiling revealed that 5mC level decreased and 5hmC level increased in the hypothalamus than in other regions. …”

Image_5_Mast Cells Are Mediators of Fibrosis and Effector Cell Recruitment in Dermal Chronic Graft-vs.-Host Disease.tif by Ethan Strattan (7514342)